Firefly Neuroscience Inc. announced that it has entered into a Warrants Cancellation and Exchange Agreement with certain investors, under which previously issued warrants from June 2025 will be exchanged for new warrants to purchase the company’s common stock. The transaction is being conducted as a private placement, relying on exemptions from registration under the Securities Act. If all new warrants are exercised, Firefly Neuroscience could receive gross proceeds of approximately $400,000, which the company plans to use for working capital and general corporate purposes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Firefly Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-123943), on December 19, 2025, and is solely responsible for the information contained therein.
Comments